Beijing Wantai Biological's Recombinant RSV Vaccine Approved for Clinical Trials

Stock News

Mar 16

Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd. (603392.SH) announced that its wholly-owned subsidiary, Wantai Canghai, has received a clinical trial approval notice from the National Medical Products Administration for its recombinant respiratory syncytial virus (RSV) vaccine (CHO cell). The recombinant RSV vaccine (CHO cell) was jointly developed by Xiamen University and Wantai Canghai. It is a recombinant protein vaccine produced using genetic engineering technology and CHOZN® cells. Its main active ingredient is a self-developed prefusion conformation membrane fusion protein F of RSV. Preclinical data indicate that the vaccine has a favorable safety profile and can induce RSV-specific protective immune responses in various animal models, including mice, rats, cotton rats, and cynomolgus monkeys.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/news/1131987515"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1131987515\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1131987515?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-16 16:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1131987515","market":"sg","top_or_hot":-1,"title":"Beijing Wantai Biological's Recombinant RSV Vaccine Approved for Clinical Trials","media":"Stock News","content":"<p>Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd. (603392.SH) announced that its wholly-owned subsidiary, Wantai Canghai, has received a clinical trial approval notice from the National Medical Products Administration for its recombinant respiratory syncytial virus (RSV) vaccine (CHO cell). The recombinant RSV vaccine (CHO cell) was jointly developed by Xiamen University and Wantai Canghai. It is a recombinant protein vaccine produced using genetic engineering technology and CHOZN® cells. Its main active ingredient is a self-developed prefusion conformation membrane fusion protein F of RSV. Preclinical data indicate that the vaccine has a favorable safety profile and can induce RSV-specific protective immune responses in various animal models, including mice, rats, cotton rats, and cynomolgus monkeys.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beijing Wantai Biological's Recombinant RSV Vaccine Approved for Clinical Trials</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeijing Wantai Biological's Recombinant RSV Vaccine Approved for Clinical Trials\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-03-16 16:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd. (603392.SH) announced that its wholly-owned subsidiary, Wantai Canghai, has received a clinical trial approval notice from the National Medical Products Administration for its recombinant respiratory syncytial virus (RSV) vaccine (CHO cell). The recombinant RSV vaccine (CHO cell) was jointly developed by Xiamen University and Wantai Canghai. It is a recombinant protein vaccine produced using genetic engineering technology and CHOZN® cells. Its main active ingredient is a self-developed prefusion conformation membrane fusion protein F of RSV. Preclinical data indicate that the vaccine has a favorable safety profile and can induce RSV-specific protective immune responses in various animal models, including mice, rats, cotton rats, and cynomolgus monkeys.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"159646","symbol_name":"疫苗","start_time":0,"source_url":"","article_id":"1131987515","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1131987515","pubTimestamp":1773651254,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd. (603392.SH) announced that its wholly-owned subsidiary, Wantai Canghai, has received a clinical trial approval notice from the National Medical...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159646":"疫苗","603392":"万泰生物","09633":"农夫山泉","BK1200":"软饮料","BK0239":"医药制造","BK1589":"北水核心资产","LU1981816686.USD":"EASTSPRING INV ASIAN MULTI FACTOR EQUITY \"A\" (USD) ACC"},"translate_title":"北京万泰生物重组RSV疫苗获批临床","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159646":1,"603392":1,"09633":1},"content_text":"Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd. (603392.SH) announced that its wholly-owned subsidiary, Wantai Canghai, has received a clinical trial approval notice from the National Medical Products Administration for its recombinant respiratory syncytial virus (RSV) vaccine (CHO cell). The recombinant RSV vaccine (CHO cell) was jointly developed by Xiamen University and Wantai Canghai. It is a recombinant protein vaccine produced using genetic engineering technology and CHOZN® cells. Its main active ingredient is a self-developed prefusion conformation membrane fusion protein F of RSV. Preclinical data indicate that the vaccine has a favorable safety profile and can induce RSV-specific protective immune responses in various animal models, including mice, rats, cotton rats, and cynomolgus monkeys.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}